MPO and Fabry disease: These results are in line with the findings of Zheng et al. (2023), where 27 days of UPF treatment (400 mg/kg/day) significantly elevated the levels of CAT and T-SOD, and attenuated myeloperoxidase (MPO) and MDA production in the colon tissues of FD-induced mice [33], suggesting that UPF exerts a protective effect against inflammation-associated oxidative damage by enhancing endogenous antioxidant defences and reducing lipid peroxidation, thereby contributing to the amelioration of oxidative stress in various inflammatory disease models.